H.R. 586

119th Congress

In Committee

Vietnam Veterans Liver Fluke Cancer Study Act

Sponsored byRepublican:Rep. LaLota, Nick [R-NY-1]NY· Introduced 21 janvier 2025
Open on Congress.gov

8

Cosponsors

13

Actions

0

Amendments

2

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

8 avril 2025·1 year ago

Summary

Introduced in House · Updated 3 mars 2025

Vietnam Veterans Liver Fluke Cancer Study Act

This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.

The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Timeline

13 actions

  1. Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

    8 avril 2025 · IntroReferral

  2. DEBATE - The House proceeded with forty minutes of debate on H.R. 586.

    7 avril 2025 · Floor

  3. Considered under suspension of the rules. (consideration: CR H1435-1437)

    7 avril 2025 · Floor

  4. At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    7 avril 2025 · Floor

  5. Considered as unfinished business. (consideration: CR H1441-1442)

    7 avril 2025 · Floor

  6. Mr. Bost moved to suspend the rules and pass the bill, as amended.

    7 avril 2025 · Floor

  7. On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436)

    7 avril 2025 · Floor

  8. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)

    7 avril 2025 · Floor

  9. Motion to reconsider laid on the table Agreed to without objection.

    7 avril 2025 · Floor

  10. Referred to the Subcommittee on Health.

    25 février 2025 · Committee

  11. Referred to the House Committee on Veterans' Affairs.

    21 janvier 2025 · IntroReferral

  12. Introduced in House

    21 janvier 2025 · IntroReferral

  13. Introduced in House

    21 janvier 2025 · IntroReferral

Sponsorship

8 cosponsors

Sponsor

Republican:Rep. LaLota, Nick [R-NY-1]NY

Cosponsors

  • Democrat563%
  • Republican338%

Classification

Policy area

Armed Forces and National Security

Legislative subjects

AsiaCancerConflicts and warsCongressional oversightGovernment studies and investigationsHealth information and medical recordsMedical researchVeterans' medical careVietnam

Committees

2

  • Veterans' Affairs Committee

    House · Standing

    • Referred To21 Jan 2025

    • Health Subcommittee

      • Referred to25 Feb 2025

  • Veterans' Affairs Committee

    Senate · Standing

    • Referred To8 Apr 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 5 on 21 janvier 2025 to 8 on 7 avril 2025.

Pelosi Tracker
Follow on XRejoignez notre Discord
PolitiquesProjets de loiPortefeuillesTarifsÀ proposMentions légalesConditions d'utilisationPolitique de confidentialité
English
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.